Carbamazepine polymorphism: A re-visitation using Raman imaging
Open Access
- 1 March 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 617, 121632
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Recrystallization of Commercial Carbamazepine Samples—A Strategy to Control Dissolution VariabilityPharmaceutics, 2012
- Variability in commercial carbamazepine samples – Impact on drug releaseInternational Journal of Pharmaceutics, 2011
- Lean Raman Imaging for Rapid Assessment of Homogeneity in Pharmaceutical FormulationsApplied Spectroscopy, 2010
- Comparative In Vitro Study of Six Carbamazepine ProductsAAPS PharmSciTech, 2008
- Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 2006
- Quantitative analysis of less soluble form IV in commercial carbamazepine (form III) by diffuse reflectance fourier transform spectroscopy (DRIFTS) and lazy learning algorithmAnalytica Chimica Acta, 2005
- Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphsJournal of Pharmaceutical and Biomedical Analysis, 2004
- General principles of pharmaceutical solid polymorphism A supramolecular perspectiveAdvanced Drug Delivery Reviews, 2004
- Time‐resolved X‐ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepineJournal of Pharmaceutical Sciences, 2001
- Effect of type and extent of crystalline order on chemical and physical stability of carbamazepineInternational Journal of Pharmaceutics, 1989